Conference abstract · 2017
Conference abstractPublished 10 Mar 2016
Toward potent immunotherapy drugs: Rational design of inhibitors of the immune checkpoints proteins
University of Alberta, Canada
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Immune checkpoints constitute a distinctive set of proteins that belong to the B7 family. The engagement of these transmembrane receptors with their ligands provides critical signals to inhibit T-cell activation and promote for immune tolerance. Tumor and infected cells can hide from the immune system by over expressing these proteins leading to T-cell exhaustion. Blocking these interactions emerged as a âÂ?Â?game changingâÂ?Â? approach in anticancer and antiviral immunotherapy. Current immune checkpoints blockers are limited to antibodies and possess a unique mode of action; they reactivate exhausted T-cells, allowing them to proliferate and recognize and kill infected and tumor cells. Despite their outstanding success the ultimate therapeutic target or combination of targets from these proteins is still to be determined. They are highly limited by their substantial cost and severe side effects. Our team at the University of Alberta has been focused on developing less expensive and more controlled inhibitors for the immune checkpoints. Our approach combines state-of-the-art computational modeling techniques with cutting-edge experimental technologies to design and develop small molecule inhibitors for these proteins. During this talk, an overview about our program will be presented with updates on our recent progress toward this goal.
Subjects
Infectious DiseasesMicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 7 Dec 2015
Rational Design Of Immune Checkpoints’ Small Molecule Inhibitors
Opinion · 26 Feb 2025
Checkpoint Inhibitors: Unlocking the Power of the Immune System
Editorial · 3 Feb 2022
Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?
Conference abstract
Drug design against nosocomial infections: Homology modelling and Virtual screening in shikimate dehydrogenase from Enterobacter cloacae to find potential inhibitors
More from this journal
The newest in Virology & Mycology.
Perspective · 3 Apr 2025
Biofilm Formation and Drug Resistance in Viral and Fungal Coinfections
Perspective · 3 Apr 2025
Climate Change and the Evolution of Virulent Viral and Fungal Strains
Commentary · 3 Apr 2025
Next Generation Diagnostics for Rapid Detection of Viruses and Fungi
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalVirology & Mycology
- SubjectInfectious Diseases
- SubjectMicrobiology
- BylineArticles whose byline prints “Khaled Barakat”

